We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$471B
AUM Growth
+$12.9B
Cap. Flow
-$11.2B
Cap. Flow %
-2.38%
Top 10 Hldgs %
12.86%
Holding
2,627
New
87
Increased
929
Reduced
999
Closed
89

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.73B
2
ECL icon
Ecolab
ECL
+$1.17B
3
CCI icon
Crown Castle
CCI
+$906M
4
PSX icon
Phillips 66
PSX
+$775M
5
GILD icon
Gilead Sciences
GILD
+$756M

Sector Composition

Rank Sector Weight
1 Healthcare 19.84%
2 Consumer Discretionary 13.93%
3 Financials 13.41%
4 Industrials 12.4%
5 Technology 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YTEN
2551
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
-$21K
VJET
2552
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
-62,320
Closed -$4.32M
BKCC
2553
DELISTED
BlackRock Capital Investment Corporation
BKCC
-27,200
Closed -$232K
BFX
2554
DELISTED
BowFlex Inc.
BFX
-11,900
Closed -$142K
AERI
2555
DELISTED
Aerie Pharmaceuticals
AERI
-502,224
Closed -$10.4M
EPZM
2556
DELISTED
Epizyme, Inc
EPZM
-585,771
Closed -$15.9M
NAV
2557
DELISTED
Navistar International
NAV
-19,100
Closed -$629K
GMO
2558
DELISTED
General Moly, Inc.
GMO
-22,800
Closed -$17K
STML
2559
DELISTED
Stemline Therapeutics, Inc.
STML
-54,473
Closed -$679K
LTM
2560
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
-505,132
Closed -$5.74M
CSFL
2561
DELISTED
CenterState Bank Corporation Common Stock
CSFL
-479,290
Closed -$4.96M
MLNX
2562
DELISTED
Mellanox Technologies, Ltd.
MLNX
-797,177
Closed -$35.8M
HOS
2563
DELISTED
Hornbeck Offshore Services, Inc.
HOS
-7,300
Closed -$239K
AREX
2564
DELISTED
Approach Resources Inc.
AREX
-14,100
Closed -$204K
NWY
2565
DELISTED
New York & Co Inc
NWY
-1,446,500
Closed -$4.38M
WEB
2566
DELISTED
Web.com Group, Inc.
WEB
-16,700
Closed -$333K
UTEK
2567
DELISTED
Ultratech Inc.
UTEK
-74,300
Closed -$1.69M
ZLTQ
2568
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
-142,923
Closed -$3.23M
NMBL
2569
DELISTED
Nimble Storage, Inc.
NMBL
-490,715
Closed -$12.7M
ACTS
2570
DELISTED
Actions Semiconductor Co
ACTS
-740,000
Closed -$1.61M
CSH
2571
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
-18,425
Closed -$366K
WY.PRA
2572
DELISTED
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
-101,550
Closed -$5.48M
SSE
2573
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
-65,322
Closed -$1.55M
SZYM
2574
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
-1,070,020
Closed -$7.98M
LF
2575
DELISTED
LEAPFROG ENTERPRISES INC.
LF
-14,800
Closed -$89K

Similar funds

T. Rowe Price Associates's Q4 2014 Portfolio in Review

As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
  • T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
  • T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
  • T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
  • T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.

Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.